EMA Authorised: Copalia HCT (amlodipine;valsartan;hydrochlorothiazide) — Novartis Europharm Limited

View source ↗

Summary

The European Medicines Agency authorised Copalia HCT, a fixed-dose combination tablet containing amlodipine, valsartan and hydrochlorothiazide, for hypertension…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Copalia HCT (amlodipine; valsartan; hydrochlorothiazide)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Novartis Europharm Limited. Decision date: 05/02/2026